Latest News & Updates | Lymphoma Canada Announcements

News

Lymphoma Changes Holidays forever

Dear Friend, I would like to tell you a little bit about a person that…

adminDecember 5, 2017

News

There is hope with CLL

Getting Back in the Sleigh Spreading joy as Santa is what the holidays are all…

adminNovember 30, 2017

News

CanCertainty Coalition Applauds The Ontario PC Party’s Commitment To Equality For Cancer Patients

CanCertainty Coalition Applauds The Ontario PC Party's Commitment To Equality For Cancer Patients – The…

adminNovember 27, 2017

image_name_-_follicular-lymphoma-4-ln022-1-4

News

Obinutuzumab Reduces Risk of Disease Progression in Follicular Lymphoma

Obinutuzumab Reduces Risk of Disease Progression in Follicular Lymphoma Interim analysis of the GALLIUM (NCT01332968)…

adminOctober 19, 2017

Events News

Spaghetti sauce for lymphoma

Nick was diagnosed with non Hodgkin's Lymphoma in September 2013. Once treated and in remission,…

adminOctober 2, 2017

News

CANCER PATIENTS CELEBRATE NEW PROGRAM FOR TAKE-HOME CANCER MEDICATIONS IN NOVA SCOTIA

CANCER PATIENTS CELEBRATE NEW PROGRAM FOR TAKE-HOME CANCER MEDICATIONS IN NOVA SCOTIA -- Province’s investment…

adminSeptember 27, 2017

News

Hodgkin Lymphoma Patient Survey: Experience with Nivolumab (Opdivo)

Hodgkin Lymphoma Patient Survey: Experience with Nivolumab (Opdivo) If you have or had Hodgkin lymphoma…

adminSeptember 19, 2017

Events News

Count Down to World Lymphoma Awareness Day

#EverythingChanges for World Lymphoma Awareness Day No one ever expects to sit in the doctor’s…

adminSeptember 6, 2017

News

Hodgkin Lymphoma Patient Survey: Experience with Brentuximab-vedotin (Adcetris)

Hodgkin Lymphoma Patient Survey: Experience with Brentuximab-vedotin (Adcetris) If you have or had Hodgkin lymphoma…

adminJuly 26, 2017

News

Health Canada Approves ADCETRIS® (Brentuximab Vedotin) for the Post-ASCT Consolidation Treatment of Patients with Hodgkin Lymphoma at Increased Risk of Relapse or Progression

Health Canada Approves ADCETRIS® (Brentuximab Vedotin) for the Post-ASCT Consolidation Treatment of Patients with Hodgkin…

adminJuly 26, 2017

Mon	Tue	Wed	Thu	Fri	Sat	Sun
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

News & Media

Lymphoma Changes Holidays forever

There is hope with CLL

CanCertainty Coalition Applauds The Ontario PC Party’s Commitment To Equality For Cancer Patients

Obinutuzumab Reduces Risk of Disease Progression in Follicular Lymphoma

Spaghetti sauce for lymphoma

CANCER PATIENTS CELEBRATE NEW PROGRAM FOR TAKE-HOME CANCER MEDICATIONS IN NOVA SCOTIA

Hodgkin Lymphoma Patient Survey: Experience with Nivolumab (Opdivo)

Count Down to World Lymphoma Awareness Day

Hodgkin Lymphoma Patient Survey: Experience with Brentuximab-vedotin (Adcetris)

Health Canada Approves ADCETRIS® (Brentuximab Vedotin) for the Post-ASCT Consolidation Treatment of Patients with Hodgkin Lymphoma at Increased Risk of Relapse or Progression

Are you a patient?

Are you a healthcare professional?

Upcoming Events

Contact Us

Donate

Careers

Join Our Mailing List